Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Schoen Klinik bidding for Priory Group

HBI understands German psychiatric operator Schoen Klinik is looking to buy Priory Group, the UK's largest psychiatric provider by revenue. The German contender would be a good fit for the company which has been on the block for almost a year. We talk to a market expert to find out more.

IHH looking to sell outlying assets

The new CEO of IHH Healthcare is considering divesting some assets as he shifts strategy to focus on geographical clusters. Which of its 80 hospitals could face the block? HBI examines.

Russian billionaire buys Baring Vostok’s EMC stake

PE firm Baring Vostok has offloaded its 27.8% stake in Moscow hospital European Medical Center to MedInvestGroup, the company of billionaire Viktor Kharitonin which is building a national oncology network. It coincides with reports that the court case against Baring founding partner Michael Calvey might soon be wrapped up.

KKR pulls out of Dentix deal

Global investment firm KKR has pulled out of a deal to take a majority stake in Spain’s biggest dental chain, Dentix, the company exclusively tells HBI. It is KKR's second high-profile decision not to invest in a large healthcare group this week.

CVC “speaking with advisors” about Elsan sale

CVC Capital Partners is talking to advisors about sale options for Elsan, the large French hospital group it has owned since 2014, according to reports. We speculate on potential buyers.

Mediclinic cleared to buy hospitals in South Africa

EMEA hospital group Mediclinic International has been cleared to acquire three hospitals in South Africa, after the merger was initially blocked by competition authorities. Does this signal the start of the Big Three hospitals "mopping up" the remaining c.20% of the market?

Korian targets top slot after large Dutch acquisition

Pan-European nursing home group Korian has made its largest Dutch acquisition to date, putting it in touching distance of rival Orpea for the number one market position in the Netherlands. We speak to a local consultant who gives us background on the assets.

Dr Lal Pathlabs acquires two labs

India's largest diagnostics chain by revenue, NSE-listed Dr Lal Pathlabs, is acquiring two pathological laboratories for a total of around $1m (€900m).

Find Us